Literature DB >> 17619858

Spatial deficits in a mouse model of Parkinson disease.

Elvira De Leonibus1, Tiziana Pascucci, Sebastien Lopez, Alberto Oliverio, Marianne Amalric, Andrea Mele.   

Abstract

RATIONALE: Accumulating evidence in humans demonstrated that visuo-spatial deficits are the most consistently reported cognitive abnormalities in Parkinson disease (PD). These deficits have been generally attributed to cortical dopamine degeneration. However, more recent evidence suggests that dopamine loss in the striatum is responsible for the visuo-spatial abnormalities in PD. Studies based on animal models of PD did not specifically address this question.
OBJECTIVES: Thus, the first goal of this study was to analyze the role of dopamine within the dorsal striatum in spatial memory. We tested bilateral 6-OHDA striatal lesioned CD1 mice in an object-place association spatial task. Furthermore, to see whether the effects were selective for spatial information, we measured how the 6-OHDA-lesioned animals responded to a non-spatial change and learned in the one-trial inhibitory avoidance task.
RESULTS: The results demonstrated that bilateral (approximately 75%) dopamine depletion of the striatum impaired spatial change discrimination. On the contrary, no effect of the lesion was observed on non-spatial novelty detection or on passive avoidance learning.
CONCLUSIONS: These results confirm that dopamine depletion is accompanied by cognitive deficits and demonstrate that striatal dopamine dysfunction is sufficient to induce spatial information processing deficits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619858     DOI: 10.1007/s00213-007-0862-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  43 in total

1.  Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.

Authors:  Hans J C Berger; Alexander R Cools; Martin W I M Horstink; Wim J G Oyen; Elisabeth W M Verhoeven; Sieberen P van der Werf
Journal:  Neuropsychologia       Date:  2004       Impact factor: 3.139

2.  Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.

Authors:  Simon J G Lewis; Aleksandra Slabosz; Trevor W Robbins; Roger A Barker; Adrian M Owen
Journal:  Neuropsychologia       Date:  2004-12-21       Impact factor: 3.139

3.  Memory for spatial location in 'de novo' parkinsonian patients.

Authors:  B Pillon; S Ertle; B Deweer; A M Bonnet; M Vidailhet; B Dubois
Journal:  Neuropsychologia       Date:  1997-03       Impact factor: 3.139

4.  Recall and recognition memory in Parkinson's disease.

Authors:  E K Breen
Journal:  Cortex       Date:  1993-03       Impact factor: 4.027

5.  Selective effects of partial striatal 6-OHDA lesions on information processing in the rat.

Authors:  Alain Courtière; Jeannine Hardouin; Virginie Locatelli; Nathalie Turle-Lorenzo; Marianne Amalric; Franck Vidal; Thierry Hasbroucq
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

6.  The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function.

Authors:  P Collins; L S Wilkinson; B J Everitt; T W Robbins; A C Roberts
Journal:  Behav Neurosci       Date:  2000-02       Impact factor: 1.912

7.  Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease.

Authors:  E Farina; G Gattellaro; S Pomati; E Magni; A Perretti; A P Cannatà; P Nichelli; C Mariani
Journal:  Eur J Neurol       Date:  2000-05       Impact factor: 6.089

8.  Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease.

Authors:  Simon J G Lewis; Roshan Cools; Trevor W Robbins; Anja Dove; Roger A Barker; Adrian M Owen
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

9.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

10.  L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

Authors:  Roshan Cools; Simon J G Lewis; Luke Clark; Roger A Barker; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2006-07-12       Impact factor: 7.853

View more
  32 in total

1.  The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.

Authors:  Alin Ciobica; Zenovia Olteanu; Manuela Padurariu; Lucian Hritcu
Journal:  J Physiol Biochem       Date:  2011-10-18       Impact factor: 4.158

2.  A double dissociation revealing bidirectional competition between striatum and hippocampus during learning.

Authors:  Anni S Lee; Ronald S Duman; Christopher Pittenger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

3.  Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Dopamine depletion in either the dorsomedial or dorsolateral striatum impairs egocentric Cincinnati water maze performance while sparing allocentric Morris water maze learning.

Authors:  Amanda A Braun; Robyn M Amos-Kroohs; Arnold Gutierrez; Kerstin H Lundgren; Kim B Seroogy; Matthew R Skelton; Charles V Vorhees; Michael T Williams
Journal:  Neurobiol Learn Mem       Date:  2014-11-13       Impact factor: 2.877

5.  Mice Lacking GPR88 Show Motor Deficit, Improved Spatial Learning, and Low Anxiety Reversed by Delta Opioid Antagonist.

Authors:  Aura C Meirsman; Julie Le Merrer; Lucie P Pellissier; Jorge Diaz; Daniel Clesse; Brigitte L Kieffer; Jérôme A J Becker
Journal:  Biol Psychiatry       Date:  2015-06-06       Impact factor: 13.382

6.  Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.

Authors:  Francesca Managò; Sebastien Lopez; Alberto Oliverio; Marianne Amalric; Andrea Mele; Elvira De Leonibus
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

Review 7.  Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities.

Authors:  Barbara Picconi; Elvira De Leonibus; Paolo Calabresi
Journal:  J Neural Transm (Vienna)       Date:  2018-02-28       Impact factor: 3.575

8.  Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Heather L Melrose; Thomas Mosley; Jun Ming Wang
Journal:  Neurobiol Learn Mem       Date:  2017-05-06       Impact factor: 2.877

9.  Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.

Authors:  R Garrett Morgan; Jeffrey T Gibbs; Erica J Melief; Nadia O Postupna; Emily E Sherfield; Angela Wilson; C Dirk Keene; Thomas J Montine; Richard D Palmiter; Martin Darvas
Journal:  Exp Neurol       Date:  2015-06-14       Impact factor: 5.330

10.  Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.